- 57% of former adolescent inpatients with schizophrenia spectrum disorders were adherent to antipsychotics (MPR ≥0.8) during follow-up.
- Clozapine and mood stabilisers were associated with significantly reduced odds of nonadherence (clozapine OR 0.18; mood stabilisers OR 0.20).
- Medication adherence showed no association with family size, birth order, or adverse childhood experiences in this cohort.
J Nerv Ment Dis. 2026 Nov 9. doi: 10.1097/NMD.0000000000001900. Online ahead of print.
ABSTRACT
BACKGROUND: Schizophrenia spectrum disorders (SSD) are severe mental illnesses, and antipsychotic medication is their main treatment. Medication adherence can be evaluated using medication possession ratios (MPR). We investigated antipsychotic MPRs in former adolescent psychiatric inpatients diagnosed with SSD and its association with familial factors.
METHODS: This follow-up study included 508 adolescents hospitalized for psychiatric care in Northern Finland (2001-006). During hospitalization, participants were interviewed using EuropASI and K-SADS-PL. Follow-up data on antipsychotic purchases came from Social Insurance Institution of Finland up to 6/2023, and diagnoses from Finnish Care Register up to 8/2023. The analysis focused on 79 participants with SSD.
RESULTS: A total of 57% were adherent (MPR ≥0.8). Clozapine (OR 0.18, 95% CI: 0.06-0.58) and mood stabilizers (OR 0.20, 95% CI: 0.05-0.87) were associated with lowered likelihood for nonadherence. Medication adherence was not associated with family size, birth order, and adverse childhood experiences.
CONCLUSIONS: Effective medication choice is crucial for SSD treatment.
PMID:43013353 | DOI:10.1097/NMD.0000000000001900
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

